July 12 (Reuters) - Nvidia NVDA.O invested $50 million to speed up training of biotech firm Recursion's RXRX.O artificial intelligence models for drug discovery, which the chip designer can then ...

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he insists it will actually ship products.

The business of using artificial intelligence to find new drugs is starting to consolidate. The AI-powered drug discovery firm Recursion Pharmaceuticals will buy rival Exscientia in an all-stock deal ...

Recursion Pharmaceuticals, a drug discovery company that applies artificial intelligence to biology, is shoring up its technology platform by buying two startups that bolster its chemistry ...

Anthropic's research suggests AI is increasingly used to develop and improve new AI systems, with Claude now writing over 80% ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive early clinical data from its AI driven drug discovery programs. The company highlighted progress in oncology and rare disease candidates in ...

Evidence that AI-fueled drug discovery is the way forward is hard to find now, but that could change in 2025. After merging with Exscientia, Recursion will have 10 clinical readouts to look forward to ...

Anthropic has warned that recursive-self-improving AI could be on the horizon, but the truth is the company is more ...

Analysts and investors have been awaiting more proof that Recursion Pharma’s extensive and homegrown datasets can offer drug discovery platforms a speed-to-clinic edge. A $50 million investment the ...

As the race to build ever more powerful artificial intelligence systems accelerates, one of the industry's leading players is ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion Pharmaceuticals announced positive Phase 1b/2 results from its ongoing TUPELO trial ...

The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...